Mycronic AB (publ) (STO:MYCR)
Sweden · Delayed Price · Currency is SEK 330.40
-3.40 (-1.02%)
Aug 14, 2026, 5:29 PM CET
Mycronic AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 8,649 | 7,938 | 7,057 | 5,706 | 5,119 | 4,635 | |
Revenue Growth | 7.49% | 12.48% | 23.68% | 11.47% | 10.44% | 19.40% |
Cost of Revenue | 3,969 | 3,736 | 3,336 | 2,850 | 2,831 | 2,321 |
Gross Profit | 4,680 | 4,202 | 3,721 | 2,856 | 2,288 | 2,314 |
Selling, General & Admin | 1,295 | 1,173 | 989 | 996 | 889 | 769 |
Research & Development | 1,102 | 978 | 747 | 653 | 638 | 548 |
Other Operating Expenses | -98 | -37 | -31 | -44 | -98 | -55 |
Operating Expenses | 2,299 | 2,114 | 1,705 | 1,605 | 1,429 | 1,262 |
Operating Income | 2,381 | 2,088 | 2,016 | 1,251 | 859 | 1,052 |
Interest Expense | -43 | -17 | -15 | -13 | -13 | -14 |
Interest & Investment Income | 30 | 46 | 78 | 40 | 9 | 11 |
Currency Exchange Gain (Loss) | -77 | -77 | 6 | -16 | 12 | 27 |
Other Non Operating Income (Expenses) | 1 | 1 | 1 | - | 1 | - |
EBT Excluding Unusual Items | 2,292 | 2,041 | 2,086 | 1,262 | 868 | 1,076 |
Merger & Restructuring Charges | -71 | -71 | -2 | - | - | -30 |
Gain (Loss) on Sale of Assets | - | - | - | - | 23 | - |
Pretax Income | 2,221 | 1,970 | 2,084 | 1,262 | 891 | 1,046 |
Income Tax Expense | 485 | 410 | 396 | 266 | 154 | 219 |
Earnings From Continuing Operations | 1,736 | 1,560 | 1,688 | 996 | 737 | 827 |
Minority Interest in Earnings | -1 | - | -5 | 2 | 4 | 1 |
Net Income | 1,735 | 1,560 | 1,683 | 998 | 741 | 828 |
Net Income to Common | 1,735 | 1,560 | 1,683 | 998 | 741 | 828 |
Net Income Growth | -12.11% | -7.31% | 68.64% | 34.68% | -10.51% | 19.31% |
Shares Outstanding (Basic) | 195 | 195 | 195 | 195 | 195 | 195 |
Shares Outstanding (Diluted) | 195 | 195 | 195 | 195 | 195 | 195 |
Shares Change | -0.00% | -0.00% | 0.01% | 0.03% | -0.10% | -0.06% |
EPS (Basic) | 8.89 | 7.99 | 8.62 | 5.11 | 3.80 | 4.24 |
EPS (Diluted) | 8.88 | 7.99 | 8.62 | 5.11 | 3.79 | 4.24 |
EPS Growth | -12.16% | -7.31% | 68.69% | 34.65% | -10.49% | 19.43% |
Free Cash Flow | 1,883 | 1,316 | 1,748 | 1,505 | 746 | 956 |
Free Cash Flow Per Share | 9.64 | 6.74 | 8.95 | 7.71 | 3.82 | 4.89 |
Dividend Per Share | 3.250 | 3.250 | 2.750 | 2.250 | 1.750 | 1.500 |
Dividend Growth | 18.18% | 18.18% | 22.22% | 28.57% | 16.67% | 0% |
Gross Margin | 54.11% | 52.94% | 52.73% | 50.05% | 44.70% | 49.92% |
Operating Margin | 27.53% | 26.30% | 28.57% | 21.92% | 16.78% | 22.70% |
Profit Margin | 20.06% | 19.65% | 23.85% | 17.49% | 14.47% | 17.86% |
Free Cash Flow Margin | 21.77% | 16.58% | 24.77% | 26.38% | 14.57% | 20.63% |
EBITDA | 2,591 | 2,260 | 2,145 | 1,388 | 994 | 1,152 |
EBITDA Margin | 29.96% | 28.47% | 30.39% | 24.32% | 19.42% | 24.85% |
D&A For EBITDA | 210 | 172 | 129 | 137 | 135 | 100 |
EBIT | 2,381 | 2,088 | 2,016 | 1,251 | 859 | 1,052 |
EBIT Margin | 27.53% | 26.30% | 28.57% | 21.92% | 16.78% | 22.70% |
Effective Tax Rate | 21.84% | 20.81% | 19.00% | 21.08% | 17.28% | 20.94% |